Basic Information
LncRNA/CircRNA Name | ENSG00000241684 |
Synonyms | lncADAMTS9-AS2 |
Region | GRCh38_3:64684909-65011468 |
Ensemble | ENSG00000241684 |
Refseq | NR_038264 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | clear cell renal cell carcinoma |
ICD-0-3 | C64.9 |
Methods | Microarray, qRT-PCR |
Sample | ccRCC tissues, RCC cell lines (786-O) |
Expression Pattern | down-regulated |
Function Description | the expression of three LncRNA (ENSG00000241684, ENSG00000231721 and NEAT1) were significantly downregulated in advanced ccRCC.LncRNA ENSG00000241684 had significant hazard ratios for predicting clinical outcome. LncRNA ENSG00000241684 expression was negatively correlated with pTNM stage. Overexpression of ENSG00000241684 significantly impaired cell proliferation and reduced the invasion ability in 786-O and ACHN cells. |
Pubmed ID | 29433989 |
Year | 2018 |
Title | Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma. |
External Links
Links for ENSG00000241684 | GenBank HGNC NONCODE |
Links for clear cell renal cell carcinoma | OMIM COSMIC |